Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period
Eye2012Vol. 26(7), pp. 958–966
Citations Over Time
Related Papers
- → Ranibizumab for Neovascular Age-Related Macular Degeneration(2006)5,818 cited
- → Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration(2021)81 cited
- → PREDICTED BIOLOGIC ACTIVITY OF INTRAVITREAL BEVACIZUMAB(2007)67 cited
- → Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment(2014)50 cited
- → Real‐world experience with brolucizumab in pro re nata regimen in patients with neovascular age‐related macular degeneration previously treated with ranibizumab and aflibercept and without control of subretinal fluid(2024)